Evaluation of ENMD-2076 in combination with anti-PD1 in syngeneic cancer models

被引：1
|
作者：
Fletcher, Graham C.
Kiarash, Reza
Bray, Mark R.
Hu, Amanda S.
Ren, Ken K.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1642
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1642
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ENMD-2076 exerts antiangiogenic and antiproliferative activity against human colorectal cancer (CRC) xenograft models
    Tentler, J. J.
    Pierce, E. L. B.
    Serkova, N. J.
    Pitts, T. M.
    Bray, M. R.
    Fletcher, G. C.
    Eckhardt, S. G.
    EJC SUPPLEMENTS, 2008, 6 (12): : 92 - 92
  • [2] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumour mouse models
    Sparks, R.
    Rolland, S.
    Klinz, S.
    Meyer-Losic, F.
    Nakhle, J.
    Delille, R.
    de Boisferonc, M. Hillairet
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models
    Rolland, S.
    Klinz, S. G.
    Meyer-Losic, F.
    Nahkle, J.
    Delille, R.
    de Boisferon, M. Hillairet
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Evaluation of niraparib in combination with anti-PD1/anti-PD-L1 in preclinical models
    Wang, Sarah
    Sun, Kaiming
    Xiao, Yonghong
    Feng, Bin
    Mikule, Keith
    Ramaswamy, Sridhar
    Hanke, Jeffrey
    Wang, Jing
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models
    Diamond, Jennifer R.
    Eckhardt, S. Gail
    Tan, Aik Choon
    Newton, Timothy P.
    Selby, Heather M.
    Brunkow, Kelsey L.
    Kachaeva, Maria I.
    Varella-Garcia, Marileila
    Pitts, Todd M.
    Bray, Mark R.
    Fletcher, Graham C.
    Tentler, John J.
    CLINICAL CANCER RESEARCH, 2013, 19 (01) : 291 - 303
  • [6] A phase II study of ENMD-2076 in platinum-resistant ovarian cancer.
    Matulonis, U.
    Tew, W. P.
    Matei, D.
    Behbakht, K.
    Fleming, G. F.
    Oza, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Molecular Markers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Human Colorectal Cancer (CRC) Models
    Tentler, J.
    Bagby, S. M.
    Tan, A. C.
    Pitts, T. M.
    Selby, H. M.
    McPhillips, K. L.
    Eckhardt, S. G.
    Leong, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 78 - 78
  • [8] Antitumor activity of eribulin in combination with anti-PD1 antibody in a mouse syngeneic breast cancer model
    Semba, Taro
    Tabata, Kimiyo
    Ozawa, Yoichi
    Miyano, Saori Watanabe
    Matsui, Junji
    Funahashi, Yasuhiro
    CANCER RESEARCH, 2019, 79 (13)
  • [9] In vivo activity of combinations of cytotoxic regimens with anti-PD1 and anti-PDL1 in various syngeneic cancer models
    Grasselly, Chloe
    Denis, Morgane
    Bourguignon, Aurore
    Talhi, Nolan
    Tourette, Anne
    Mathe, Doriane
    Serre, Laurent
    Jordheim, Lars Petter
    Dumontet, Charles
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Combination with a novel STING agonist significantly improves efficacy of anti-PD1 therapy in mouse syngeneic tumor models
    Perera, Samanthi A.
    Kopinja, Johnny E.
    Ma, Yanhong
    Laskey, Jason
    Chakravarthy, Kalyan
    Cui, Long
    Chen, Yiping
    Presland, Jeremy
    Sharma, Sharad
    Zhao, Shuxia
    Piesvaux, Jennifer
    Minnihan, Ellen C.
    Ferguson, Heidi
    Woo, Hyun Chong
    Knemeyer, Ian
    Kariv, Ilona
    Tse, Archie
    Cemerski, Saso
    Cumming, Jared
    Trotter, B. Wesley
    Pan, Bo-Sheng
    Addona, George H.
    Long, Brian J.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
12345